On Monday, Staar Surgical Co (NASDAQ: STAA) opened lower -4.74% from the last session, before settling in for the closing price of $29.10. Price fluctuations for STAA have ranged from $25.88 to $52.68 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 21.55%. Company’s average yearly earnings per share was noted -29.08% at the time writing. With a float of $48.96 million, this company’s outstanding shares have now reached $49.27 million.
The extent of productivity of a business whose workforce counts for 1115 workers is very important to gauge. In terms of profitability, gross margin is 78.73%, operating margin of 7.53%, and the pretax margin is 10.26%.
Staar Surgical Co (STAA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Staar Surgical Co is 0.65%, while institutional ownership is 98.02%. The most recent insider transaction that took place on Aug 12 ’24, was worth 49,957. In this transaction Director of this company bought 1,315 shares at a rate of $37.99, taking the stock ownership to the 4,208 shares. Before that another transaction happened on May 09 ’24, when Company’s 10% Owner bought 1 for $42.56, making the entire transaction worth $43. This insider now owns 10,768,431 shares in total.
Staar Surgical Co (STAA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -29.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.00% during the next five years compared to 31.51% growth over the previous five years of trading.
Staar Surgical Co (NASDAQ: STAA) Trading Performance Indicators
Check out the current performance indicators for Staar Surgical Co (STAA). In the past quarter, the stock posted a quick ratio of 5.38. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.00. Likewise, its price to free cash flow for the trailing twelve months is 51.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.44, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.85 in one year’s time.
Technical Analysis of Staar Surgical Co (STAA)
The latest stats from [Staar Surgical Co, STAA] show that its last 5-days average volume of 0.51 million was inferior to 0.71 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 74.34%. Additionally, its Average True Range was 1.31.
During the past 100 days, Staar Surgical Co’s (STAA) raw stochastic average was set at 8.32%, which indicates a significant decrease from 42.59% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 48.07% in the past 14 days, which was lower than the 53.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $30.57, while its 200-day Moving Average is $37.47. Now, the first resistance to watch is $28.53. This is followed by the second major resistance level at $29.34. The third major resistance level sits at $29.85. If the price goes on to break the first support level at $27.21, it is likely to go to the next support level at $26.70. The third support level lies at $25.89 if the price breaches the second support level.
Staar Surgical Co (NASDAQ: STAA) Key Stats
There are currently 49,276K shares outstanding in the company with a market cap of 1.37 billion. Presently, the company’s annual sales total 322,420 K according to its annual income of 21,350 K. Last quarter, the company’s sales amounted to 88,590 K and its income totaled 9,980 K.
